YUN
ActiveSummary
YUN has been active since 2011 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€3.2m) and a net result of -€1.2m. Equity is shrinking by ~23% per year across the filed fiscal years. Its solvency ranks better than 5% of 68 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.7% (low).
Checked score
Score 2025
Axes · tick = 2024
Profitability0=
Solvency0=
Growth58=
Track record100
Bankruptcy probability, 12 months
0.7%
Low
0%0.5%1.5%4%10%≥ 25%
No credit on open account
Liquidity short (current ratio 0.18 against 0.35 in 2024; short-term debt: 127% and cash: 2% of total assets), and equity is negative.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
-135.4%
Return on assets
-50.4%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 21
Relative position
BE, all sectors
reference
Manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21)
about 14% more bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025Equity per financial year
1819202122232425
2018 to 2025 · latest year -€3.2m
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 14-07-2026, 17 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
17 d early
2024
35 d early
2023
29 d early
2022
20 d early
2021
30 d early
2020
112 d early
2019
30 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 39 days before the deadline; the sector median for financial year 2024 is 9 days before the deadline, and 32% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 3 July (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsPosition in the running window
29-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What other support did companies like this one receive, and it did not?Public money How does this company compare with its sector?Sector benchmark
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, full schema
In the rankings
#4 company by total assets in Niel, Manufacturing sector
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
-€1.2m▲ 13.1%
2024 · -€1.4m
Working capital
-€2.5m▼ 93.2%
2024 · -€1.3m
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 21, Manufacture of basic pharmaceutical products and pharmaceutical preparations, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result-€2.3m▼ 33.1%-€1.6m▲ 29.9%-€1.3m▲ 15.9%-€1.1m▲ 14.2%-€946,350▲ 17.4%
Net result-€2.4mbelow the sector's middle half▼ 34.3%-€1.8mbelow the sector's middle half▲ 27.2%-€1.6mbelow the sector's middle half▲ 10.2%-€1.4mbelow the sector's middle half▲ 12.2%-€1.2mbelow the sector's middle half▲ 13.1%
Equity-€4.1mbelow the sector's middle half▼ 147%-€5.8mbelow the sector's middle half▼ 43.3%-€2.1mbelow the sector's middle half▲ 63.2%-€2.0mbelow the sector's middle half▲ 5.3%-€3.2mbelow the sector's middle half▼ 59.4%
Total assets€1.8mwithin the sector's middle half▼ 27.9%€2.1mwithin the sector's middle half▲ 15.2%€3.2mwithin the sector's middle half▲ 57.8%€2.3mwithin the sector's middle half▼ 28.1%€2.4mwithin the sector's middle half▲ 2.3%
Debt€5.8m▲ 41.9%€7.9m▲ 34.7%€5.4m▼ 31.5%€4.4m▼ 19.1%€5.6m▲ 28.8%
Working capital-€1.9mbelow the sector's middle half▼ 359%-€3.8mbelow the sector's middle half▼ 98.1%-€329,093below the sector's middle half▲ 91.3%-€1.3mbelow the sector's middle half▼ 290%-€2.5mbelow the sector's middle half▼ 93.2%
Solvency-227.1%below the sector's middle half▼ 160.8pp-282.6%below the sector's middle half▼ 55.4pp-66.0%below the sector's middle half▲ 216.6pp-86.9%below the sector's middle half▼ 20.9pp-135.4%below the sector's middle half▼ 48.5pp
Current ratio0.15below the sector's middle half▼ 0.640.11below the sector's middle half▼ 0.050.83within the sector's middle half▲ 0.720.35below the sector's middle half▼ 0.480.18below the sector's middle half▼ 0.16
Return on assets (ROA)-135.1%below the sector's middle half▼ 62.5pp-85.4%below the sector's middle half▲ 49.7pp-48.6%below the sector's middle half▲ 36.8pp-59.4%below the sector's middle half▼ 10.8pp-50.4%below the sector's middle half▲ 8.9pp
Staff (FTE)18.3▲ 17.3%16.6above the sector's middle half▼ 9.3%15.2above the sector's middle half▼ 8.4%12.2above the sector's middle half▼ 19.7%9.8within the sector's middle half▼ 19.7%
above
within
below
the middle half (P25 to P75) of NACE 21, Manufacture of basic pharmaceutical products and pharmaceutical preparations, each year against the same schema; no band under 30 filings.
Result per fiscal year
Operating resultNet result
The operating result stays negative: a loss of €946,350 in 2025 against €1.1m in 2024; the loss shrinks.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €2.4m
Fixed assets
€1.8m ▲ 10.8%
Current assets
€556,039 ▼ 18.4%
Key figures and ratios
EBITDA
-€418,358▲
2024 · -€650,283
Cash flow
-€676,798▲
2024 · -€890,517
Quick ratio
0.10▼
2024 · 0.17
Debt to equity
-1.74▲
2024 · -2.15
Interest coverage
-1.63▲
2024 · -2.73
Debt ≤ 1 year
€3.0m▲
2024 · €2.0m
Debt > 1 year
€2.6m▲
2024 · €2.4m
Income taxes
€1,747▼
2024 · €2,230
Staff costs
€516,532▼
2024 · €940,191
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 6,906 companies that looked in July 2024 the way this one looks now, 5.8% went bankrupt within 24 months and 85% are still going.
- Micro
- 10 to 20 years old
- negative equity
- a loss of 10% of the balance sheet or more
5.8%
went bankrupt
8.1%
stopped otherwise
85%
still going
A further 0.6% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a lower bankruptcy probability: 0.7% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,338 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.9% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 6,906 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Remuneration, social security and pensions62 | €1.0m | €781,119 | €1.0m | €940,191 | €516,532 | ▼ 45.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €375,691 | €464,730 | €493,453 | €495,413 | €527,991 | ▲ 6.6% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4 | €390 | €0 | - | - | - | - |
| Other operating charges640/8 | €1,884 | €4,024 | €3,142 | €2,906 | €5,809 | ▲ 99.9% |
| Non-recurring operating charges66A | €105,799 | €404,145 | €12,036 | €0 | - | - |
| Gross operating margin9900 | -€774,205 | €66,544 | €190,050 | €292,814 | €103,982 | ▼ 64.5% |
| Operating profit (loss)9901 | -€2.3m | -€1.6m | -€1.3m | -€1.1m | -€946,350 | ▲ 17.4% |
| Financial income75/76B | €1,800 | €3 | €612 | €467 | €14 | ▼ 97.1% |
| Recurring financial income75 | €1,800 | €3 | €612 | €467 | €14 | ▼ 97.1% |
| Financial charges65/66B | €146,690 | €167,519 | €240,910 | €238,472 | €256,706 | ▲ 7.6% |
| Recurring financial charges65 | €146,690 | €167,519 | €240,910 | €238,472 | €256,706 | ▲ 7.6% |
| Profit (loss) for the period before taxes9903 | -€2.4m | -€1.8m | -€1.6m | -€1.4m | -€1.2m | ▲ 13.1% |
| Income taxes67/77 | €3,285 | €2,534 | €2,819 | €2,230 | €1,747 | ▼ 21.6% |
| Profit (loss) for the period9904 | -€2.4m | -€1.8m | -€1.6m | -€1.4m | -€1.2m | ▲ 13.1% |
| Profit (loss) for the period to be appropriated9905 | -€2.4m | -€1.8m | -€1.6m | -€1.4m | -€1.2m | ▲ 13.1% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €1.8m | €2.1m | €3.2m | €2.3m | €2.4m | ▲ 2.3% |
| Fixed assets21/28 | €1.4m | €1.6m | €1.7m | €1.7m | €1.8m | ▲ 10.8% |
| Intangible fixed assets21 | €1.3m | €1.5m | €1.6m | €1.6m | €1.8m | ▲ 11.5% |
| Tangible fixed assets22/27 | €137,668 | €107,782 | €62,296 | €36,261 | €29,599 | ▼ 18.4% |
| Plant, machinery and equipment23 | €73,527 | €50,431 | €28,083 | €20,933 | €11,766 | ▼ 43.8% |
| Furniture and vehicles24 | €64,141 | €57,352 | €34,213 | €15,329 | €17,833 | ▲ 16.3% |
| Financial fixed assets28 | €7,242 | €7,242 | €7,242 | €7,242 | €7,242 | = |
| Current assets29/58 | €349,535 | €445,161 | €1.6m | €681,447 | €556,039 | ▼ 18.4% |
| Stocks and contracts in progress3 | €261,840 | €284,133 | €413,259 | €343,236 | €245,589 | ▼ 28.4% |
| Stocks30/36 | €261,840 | €284,133 | €413,259 | €343,236 | €245,589 | ▼ 28.4% |
| Amounts receivable within one year40/41 | €51,620 | €86,492 | €261,496 | €92,846 | €215,975 | ▲ 133% |
| Trade receivables40 | €5,650 | €51,477 | €167,154 | €55,099 | €214,878 | ▲ 290% |
| Other amounts receivable41 | €45,970 | €35,014 | €94,342 | €37,746 | €1,097 | ▼ 97.1% |
| Cash at bank and in hand54/58 | €10,207 | €43,628 | €849,353 | €166,532 | €48,858 | ▼ 70.7% |
| Deferred charges and accrued income490/1 | €25,868 | €30,908 | €49,821 | €78,833 | €45,616 | ▼ 42.1% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €1.8m | €2.1m | €3.2m | €2.3m | €2.4m | ▲ 2.3% |
| Equity10/15 | -€4.1m | -€5.8m | -€2.1m | -€2.0m | -€3.2m | ▼ 59.4% |
| Contributions10/11 | €64,000 | €64,000 | €5.3m | €6.8m | €6.8m | = |
| Capital10 | €64,000 | €64,000 | €5.3m | €6.8m | €6.8m | = |
| Issued capital100 | €3.8m | €3.8m | €5.3m | €6.8m | €6.8m | = |
| Uncalled capital101 | €3.8m | €3.8m | €0 | - | - | - |
| Reserves13 | €92,343 | €92,343 | €92,343 | €92,343 | €92,343 | = |
| Non-distributable reserves130/1 | €92,343 | €92,343 | €92,343 | €92,343 | €92,343 | = |
| Legal reserve130 | €1,860 | €1,860 | €1,860 | €1,860 | €1,860 | = |
| Reserves not available under the articles1311 | €90,483 | €90,483 | €90,483 | €90,483 | €90,483 | = |
| Profit (loss) carried forward14 | -€4.2m | -€6.0m | -€7.5m | -€8.9m | -€10.1m | ▼ 13.5% |
| Amounts payable17/49 | €5.8m | €7.9m | €5.4m | €4.4m | €5.6m | ▲ 28.8% |
| Amounts payable after more than one year17 | €3.5m | €3.6m | €3.4m | €2.4m | €2.6m | ▲ 7.9% |
| Financial debts170/4 | €3.5m | €3.6m | €3.4m | €2.4m | €2.6m | ▲ 7.9% |
| Other amounts payable178/9 | €0 | - | - | - | - | - |
| Amounts payable within one year42/48 | €2.3m | €4.2m | €1.9m | €2.0m | €3.0m | ▲ 54.5% |
| Current portion of amounts payable after more than one year42 | €158,570 | €101,420 | €50,323 | €652,986 | €335,319 | ▼ 48.6% |
| Financial debts43 | €1.2m | €1.2m | €1.2m | €850,000 | €1.1m | ▲ 31.3% |
| Credit institutions430/8 | €1.2m | €1.2m | €1.2m | €850,000 | €1.1m | ▲ 31.3% |
| Trade debts44 | €483,807 | €358,464 | €560,752 | €326,848 | €499,254 | ▲ 52.7% |
| Suppliers440/4 | €483,807 | €358,464 | €560,752 | €326,848 | €499,254 | ▲ 52.7% |
| Taxes, remuneration and social security45 | €127,681 | €283,022 | €141,947 | €126,352 | €153,742 | ▲ 21.7% |
| Taxes450/3 | €635 | €52,264 | €0 | €2,713 | €41,004 | ▲ 1,411% |
| Remuneration and social security454/9 | €127,046 | €230,759 | €141,947 | €123,639 | €112,738 | ▼ 8.8% |
| Other amounts payable47/48 | €337,024 | €2.3m | €0 | €7,555 | €929,301 | ▲ 12,201% |
| Accrued charges and deferred income492/3 | €35,625 | €42,494 | €37,782 | €13,935 | €13,482 | ▼ 3.3% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | -€2.4m | -€1.8m | -€1.6m | -€1.4m | -€1.2m | ▲ 13.1% |
| + Depreciation and write-downs630 | €375,691 | €464,730 | €493,453 | €495,413 | €527,991 | ▲ 6.6% |
| Operating cash flow (approximation) | -€2.0m | -€1.3m | -€1.1m | -€890,517 | -€676,798 | ▲ 24.0% |
| Investment in fixed assets (approximation) | - | -€640,711 | -€554,810 | -€475,018 | -€706,712 | ▼ 48.8% |
| Change in cash | - | €33,421 | €805,725 | -€682,822 | -€117,673 | ▲ 82.8% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
14-07
NBB filing
Annual accounts filed
fiscal year 2025 · full schema
31-03
State Gazette act
Reappointments: VERLINDEN Tom (bestuurder, gedelegeerd bestuurder) and LEMBRECHTS Paul (bestuurder, voorzitter van de raad van bestuur)Appointments: Frank Verhavert Consult (director) and Exploration (director) · Permanent representatives: Frank Verhavert and Dina De Haeck · Capital increase15 facts ▸
State Gazette act
Reappointments: VERLINDEN Tom (bestuurder, gedelegeerd bestuurder) and LEMBRECHTS Paul (bestuurder, voorzitter van de raad van bestuur)
Appointments: Frank Verhavert Consult (director) and Exploration (director) · Permanent representatives: Frank Verhavert and Dina De Haeck · Capital increase15 facts ▸
- General meeting, 20 maart 2026
- Director reappointment, VERLINDEN Tom (bestuurder, gedelegeerd bestuurder)
- Director reappointment, LEMBRECHTS Paul (bestuurder, voorzitter van de raad van bestuur)
- Director appointment, Frank Verhavert Consult (director)
- Permanent representative, Frank Verhavert
- Director appointment, Exploration (director)
- Permanent representative, Dina De Haeck
- Capital increase, €1.500.000
- Bank account, KBC Bank te Brussel
- Share issue, 381
- Capital increase, €0,03
- Capital increase, €150.000
- +3 further facts in this act
2025
26-06
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
02-07
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
11-07
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
01-07
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
08-01
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
31-03
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
30-09
Financial
Weakest financial yearnet -€2.7m
Net result drops to -€2.7m, the lowest in the series; recovery starts the following year.
02-04
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
30-03
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2017
31-03
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
1 of 14 acts read
About the unread acts
Of the 14 Belgian State Gazette acts we know for this company, 1 has been read. The other 13 have not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
under verification, last change in 2025
This board is reconstructed from a single act (26320521). A Gazette act generally publishes only CHANGES, not a full roll call, so directors unchanged since then may be missing here. The KBO register holds the complete list of function holders.
Board 4
Exploration
CurrentDirector · since 03-03-2025 · Private limited company · perm. rep.: Dina De Haeck
Frank Verhavert Consult
CurrentDirector · since 03-03-2025 · Limited partnership · perm. rep.: Frank Verhavert
Lembrechts Paul
CurrentBestuurder, voorzitter van de raad van bestuur · since 06-06-2025
Tom VERLINDEN
CurrentBestuurder, gedelegeerd bestuurder · since 06-06-2025
Day-to-day management 1
Tom VERLINDEN
CurrentBestuurder, gedelegeerd bestuurder · since 06-06-2025
Permanent representatives 2
Dina De Haeck
CurrentPermanent representative · since 03-03-2025 · for Exploration
Frank Verhavert
CurrentPermanent representative · since 03-03-2025 · for Frank Verhavert Consult
Derived from published Gazette acts. The CBE keeps the official list of function holders; we do not read it, so the two can differ.
See the function holders in the CBE →
Not every act has been read: a resignation may be missing here
13 of this company's 14 Belgian State Gazette acts have not been read yet. Appointments and resignations recorded in them are missing above: a director who resigned there may therefore still show here as sitting. The acts are in the Timeline.
Location & real-estate footprint
Registered office, Niel · 1 establishment unit since 2017
Ground area
5,028 m²
Building footprint
1,140 m²
Volume, LiDAR
994 m³
Parcel 11030C0277/00P000, Flanders · tallest building 34.5 m. Linked by address, not a title deed.
24
companies at this address
See who is registered here
1 establishment unit
Yun
since 20172.265.123.016
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11030C0277/00P000 | Flanders | 5,028 m² | 1 · 1,139 m² | 34.5 m |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Mandate history
4 people since 2025, 4 in office
- Board
- Day-to-day management
- began earlier
| Name | Functions and periods |
|---|---|
| Exploration |
|
| Frank Verhavert Consult |
|
| Lembrechts Paul |
|
| Tom VERLINDEN |
|
Structure & network
Connections & network
6 connected companiesThis company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, scroll to zoom.
Linked via shared directors
KARLOCITA
via Tom VERLINDEN · Manager
→
BEOBANK NV/SA
via Lembrechts Paul · Director
former→
De Vlaamse Radio- en Televisieomroeporganisatie
via Lembrechts Paul · Managing director
former→
Monument Assurance Belgium
via Lembrechts Paul · Director
former→
Show 2 more companies with a shared director
VLAAMSE AUDIOVISUELE REGIE
via Lembrechts Paul · Director
former→
YOUTHSTART BELGIUM
via Lembrechts Paul · Director
former→
Capital and shareholders
Shareholders according to the acts
After 3 capital increases
act of 31-03-2026 ↗
- CATAX (BE 0838.164.033) 3,427 shares · 1,500,000 EUR
- VAN dE WATER Alphons Josephus Nicolaas 241 shares · 50,000.01 EUR
- VAN dE WATER Bartholomeus Alphons Cornelis 241 shares · 50,000.01 EUR
- VAN dE WATER Josephina Elisabeth Maria 241 shares · 50,000.01 EUR
The Belgian State Gazette names shareholders only when an act mentions them; the share register itself is not published.
Capital over the years
- 31-03-2026 Capital increase of 1,500,000 EUR · to 8,314,000.03 EUR · 3,427 new shares
- 31-03-2026 Capital increase of 0.03 EUR · to 8,314,000.06 EUR · 381 new shares
- 31-03-2026 Capital increase of 150,000 EUR · to 8,464,000.03 EUR · 342 new shares
Public money · subsidies and aid
Flemish government
2022 to 2025 · 9 entries · 22,822 EUR awarded · 22,822 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2025 | 2 | 4,077 EUR | 5,127 EUR |
| 2024 | 3 | 6,516 EUR | 5,466 EUR |
| 2023 | 1 | 3,559 EUR | 3,559 EUR |
| 2022 | 3 | 8,670 EUR | 8,670 EUR |
Federal government
2025 · 1 entry · 46,800 EUR in total| Year | Department | Transactions | Amount |
|---|---|---|---|
| 2025 | Defensie | 1 | 46,800 EUR |
Budget allocations
Similar companies · same sector, comparable size
Telix Pharmaceuticals (Belgium)
BE 0695.832.765
Seneffe · Eq €515,466
MICROBELCAPS
BE 0454.591.191
Liège · Eq €574,618
Titamed
BE 0866.408.156
Kontich · Eq €462,887
EFRAX
BE 0654.897.577
Brasschaat · Eq €438,324
MEDI IMMO
BE 0534.524.042
Waterloo · Eq €623,790
Of 97 companies in sector 21209 we hold annual accounts for 74. 42 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPublic limited company
Founded28-07-2011
Fiscal year end31-12
Activities, NACEBEL 2025
21209Manufacture of basic pharmaceutical products and pharmaceutical preparations
70200Business and other management consultancy
64210Activities of holding companies
E-invoicing
Reachable via Peppol
Peppol ID
0208:0838163142
Registered
27-03-2026
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 29 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.